Mitochondrial Acetyl‐CoA Synthetase 3 is Biosignature of Gastric Cancer Progression
Wei‐Chun Chang(China Medical University), Wen‐Lung Ma(Asia University), Bi‐Hua Cheng(Chang Gung University), Wei‐Chung Cheng(Center for Devices and Radiological Health), Yao‐Ching Hung(China Medical University), Li‐Jing Ju(Chang Gung University), Mei‐Due Yang(China Medical University), Long‐Bin Jeng(National Cancer Center), Yu‐Jer Ou(Chang Gung University), Lumin Chen(China Medical University)
Cited by 50
Related Papers
Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study
|Journal of Clinical Oncology|2013|775
Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular Carcinoma
|Gastroenterology|2008|253
Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor
|Hepatology|2008|207
Androgen Receptor Promotes Hepatitis B Virus–Induced Hepatocarcinogenesis Through Modulation of Hepatitis B Virus RNA Transcription
|Science Translational Medicine|2010|198
Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis
|Endocrine Related Cancer|2014|188